Clinical Trial Update: Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial in multiple myeloma compares lenalidomide, bortezomib, and dexamethasone (RVd) against high-dose chemotherapy with stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Paul Richardson, MD | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-12-18